Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
about
Jumonji domain-containing protein 1A promotes cell growth and progression via transactivation of c-Myc expression and predicts a poor prognosis in cervical cancer.A novel inducible lentiviral system for multi-gene expression with human HSP70 promoter and tetracycline-induced promoter.Precision medicine in idiopathic pulmonary fibrosis.Applications of molecular testing in surgical pathology of the head and neck.Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.Dosing Three-Drug Combinations That Include Targeted Anti-Cancer Agents: Analysis of 37,763 Patients.Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability.Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Biologics.Effect of dihydropyrimidine dehydrogenase single nucleotide polymorphisms on prognosis of breast cancer patients with chemotherapy.Targeting HER2 in Nuclear Medicine for Imaging and Therapy.Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.Fishing for cures: The alLURE of using zebrafish to develop precision oncology therapies.When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.Precision Medicine Requires Precision Laboratories.Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors.Biomarker discovery by integrated joint non-negative matrix factorization and pathway signature analyses.Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.
P2860
Q37709105-DBB0C730-CDD4-4788-A281-C3D395CEDA01Q38761742-2F25F728-2F11-48B5-B324-9B00D42B8EB1Q38832472-29FEC758-6F4D-4A29-BEEA-C45A8B8F4082Q39070411-D1328EEE-4FB9-4B2F-85EA-18A36BCC68BEQ41233528-6DBC7234-3B6E-4FA0-AD9B-D45AA1A079DCQ45994683-054744CF-BAEB-4B31-BE4B-94793D60EDEEQ46538042-03EE1B9F-E969-4D5F-BD72-323FCEA96FBCQ47350013-F35DACA6-801F-4901-AF47-E9714DD864B0Q48277793-57B22E16-2FB6-4F5E-8492-9527AC929B56Q48534748-D0A6A38A-2064-4423-B962-A2610FCC248EQ49700421-06D10CEA-0EA4-43A1-822E-6454EA19B1BEQ50064748-FF72810E-0D37-408B-9964-EED37F8F131BQ52566012-520ED6B6-0CFE-46D0-90F0-F6AAF4B8022EQ52703978-7D9235CA-2FE8-4E82-A4E3-B4654E0D411FQ52968113-B5DB40AB-80EC-4F84-94E7-2E8E43531CF6Q54969621-D9A0A375-BC4C-493F-8742-0CA59E00F0AFQ55164552-0C3C0B20-C040-4E38-8C65-70424C3E8E24Q55474327-B73CF4FA-DA01-41D5-9ACA-F4A0317BC53CQ55710797-0CEF4FAC-BBF0-42C6-ADB3-DF3017ED7930
P2860
Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Precision Oncology Medicine: T ...... to Optimize Cancer Treatment.
@en
type
label
Precision Oncology Medicine: T ...... to Optimize Cancer Treatment.
@en
prefLabel
Precision Oncology Medicine: T ...... to Optimize Cancer Treatment.
@en
P2093
P2860
P356
P1476
Precision Oncology Medicine: T ...... to Optimize Cancer Treatment.
@en
P2093
Cindy H Chau
Douglas K Price
Keith T Schmidt
William D Figg
P2860
P304
P356
10.1002/JCPH.765
P577
2016-05-16T00:00:00Z